Evidence map›Paper›PMID 34373452›Full record

ArticleNature communications2021

FcγR engagement reprograms neutrophils into antigen cross-presenting cells that elicit acquired anti-tumor immunity.

Vijayashree Mysore, Xavier Cullere, Joseph Mears, Florencia Rosetti, Koshu Okubo, Pei X Liew, Fan Zhang, Iris Madera-Salcedo, Frank Rosenbauer, Richard M Stone and 5 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 78 papers.

0numbers the graph read from it
0cells of the map it votes in
78citing papers in PubMed
7.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

78 citing papers in PubMed, 116 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Albumin-Bound STING Agonist Reprograms HSPCs to Antitumor Neutrophils Enhancing CD8Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review

18 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 4 countries.

Vijayashree MysoreDepartment of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Xavier CullereDepartment of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Joseph MearsCenter for Data Sciences, Brigham and Women's Hospital, Boston, MA, USA.
Florencia RosettiDepartamento de Inmunología y Reumatología, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
Koshu Okubo *Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Pei X Liew *Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.ORCID 0000-0002-6065-0684
Fan ZhangCenter for Data Sciences, Brigham and Women's Hospital, Boston, MA, USA.ORCID 0000-0002-6102-2970
Iris Madera-SalcedoDepartamento de Inmunología y Reumatología, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.ORCID 0000-0002-0741-9248
Frank RosenbauerInstitute of Molecular Tumor Biology, University of Muenster, Muenster, Germany.ORCID 0000-0001-7977-9421
Richard M StoneMedical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.
Jon C AsterDepartment of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Ulrich H von AndrianDepartment of Microbiology and Immunobiology, Harvard Medical School, Boston, MA, USA.ORCID 0000-0003-4231-2283
Andrew H LichtmanDepartment of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Soumya RaychaudhuriCenter for Data Sciences, Brigham and Women's Hospital, Boston, MA, USA.
Tanya N MayadasDepartment of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. tmayadas@rics.bwh.harvard.edu.ORCID 0000-0002-3604-4457
Brigham and Women's Hospital · USHarvard University · USInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán · MXInstitute of Molecular Biology · DE

Funding

MICHIGAN MEDICAL SCIENTIST TRAINING PROGRAMT32GM007863 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI COLLINS, KATHLEEN L. · 1985 to 2024
$38.3M
Regulators of Immune Complex Mediated Neutrophil Recruitment and Tissue InjuryR01HL065095 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI MAYADAS, TANYA N · 1999 to 2025
$11.9M
Discovery and Functional Impact of Common and Rare Variants in RAR01AR063759 · NIAMS · BRIGHAM AND WOMEN'S HOSPITAL · PI Soumya Raychaudhuri · 2013 to 2026
$5.4M
Integrative analysis of high dimensional tissue molecular data to define key biological systems in autoimmune diseases (SBC)UC2AR081023 · NIAMS · BRIGHAM AND WOMEN'S HOSPITAL · PI Soumya Raychaudhuri · 2022 to 2026
$4.8M
RA-SLE Molecular Deconstruction Leadership CenterUH2AR067677 · NIAMS · BRIGHAM AND WOMEN'S HOSPITAL · PI BRENNER, MICHAEL B., RAYCHAUDHURI, SOUMYA · 2014 to 2020
$4.3M
Neutrophil plasticity in autoimmune diseaseR01AI152522 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI MAYADAS, TANYA N · 2020 to 2024
$3.2M
Functionally specialized components of disease heritability in ENCODE dataU01HG009379 · NHGRI · HARVARD SCHOOL OF PUBLIC HEALTH · PI PRICE, ALKES L, RAYCHAUDHURI, SOUMYA · 2017 to 2021
$2.5M
NHGRI NIH HHS U01 HG009379NHLBI NIH HHS R01 HL065095NIAID NIH HHS R01 AI152522NIAMS NIH HHS R01 AR063759NIAMS NIH HHS UC2 AR081023NIAMS NIH HHS UH2 AR067677NIGMS NIH HHS T32 GM007863
6 · The paper itself

Abstract

Classical dendritic cells (cDC) are professional antigen-presenting cells (APC) that regulate immunity and tolerance. Neutrophil-derived cells with properties of DCs (nAPC) are observed in human diseases and after culture of neutrophils with cytokines. Here we show that FcγR-mediated endocytosis of antibody-antigen complexes or an anti-FcγRIIIB-antigen conjugate converts neutrophils into nAPCs that, in contrast to those generated with cytokines alone, activate T cells to levels observed with cDCs and elicit CD8

Indexed as

Adaptor Proteins, Vesicular TransportAnimalsAntigen-Antibody ComplexAntigen PresentationAntigens, NeoplasmBone MarrowCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesCell MovementCell ProliferationCytokinesDendritic CellsEndocytosisHumansImmunity, InnateImmunotherapyAdaptor Proteins, Vesicular TransportAntigen-Antibody ComplexAntigens, NeoplasmCytokinesMyd88 protein, mouseMyeloid Differentiation Factor 88Reactive Oxygen SpeciesReceptors, IgGTicam1 protein, mouse

Identifiers

PMID34373452
PMCPMC8352912
OpenAlexW3189798296

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.